These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19380401)

  • 41. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    Mori AT; Norheim OF; Robberstad B
    Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
    Larson BA; Amin AA; Noor AM; Zurovac D; Snow RW
    BMC Public Health; 2006 Dec; 6():314. PubMed ID: 17196105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005.
    Thwing JI; Njau JD; Goodman C; Munkondya J; Kahigwa E; Bloland PB; Mkikima S; Mills A; Abdulla S; Kachur SP
    Trop Med Int Health; 2011 Mar; 16(3):272-9. PubMed ID: 21226795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Access to subsidized ACT and malaria treatment--evidence from the first year of the AMFm program in six districts in Uganda.
    Fink G; Dickens WT; Jordan M; Cohen JL
    Health Policy Plan; 2014 Jul; 29(4):517-27. PubMed ID: 23783833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug development: Holding out for reinforcements.
    Eisenstein M
    Nature; 2012 Apr; 484(7395):S16-8. PubMed ID: 22534526
    [No Abstract]   [Full Text] [Related]  

  • 48. Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.
    Krishna S
    Malar J; 2019 Oct; 18(1):339. PubMed ID: 31581951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A global subsidy: key to affordable drugs for malaria?
    Laxminarayan R; Gelband H
    Health Aff (Millwood); 2009; 28(4):949-61. PubMed ID: 19597193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Public health. From financing to fevers: lessons of an antimalarial subsidy program.
    Laxminarayan R; Arrow K; Jamison D; Bloom BR
    Science; 2012 Nov; 338(6107):615-6. PubMed ID: 23118173
    [No Abstract]   [Full Text] [Related]  

  • 51. Infectious diseases. Source of new hope against malaria is in short supply.
    Enserink M
    Science; 2005 Jan; 307(5706):33. PubMed ID: 15637249
    [No Abstract]   [Full Text] [Related]  

  • 52. [Malaria: a medical and economic problem].
    Bourée P
    Presse Med; 2006 Apr; 35(4 Pt 1):555-7. PubMed ID: 16614591
    [No Abstract]   [Full Text] [Related]  

  • 53. From quinine to artesunate in Africa.
    Burki T
    Lancet Infect Dis; 2011 Jun; 11(6):428-9. PubMed ID: 21770055
    [No Abstract]   [Full Text] [Related]  

  • 54. [Control of malaria: market for artemisinin and its derivatives].
    Pilloy J
    Med Trop (Mars); 2006 Dec; 66(6):554-7. PubMed ID: 17286020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the quality of prescription and dispensing of artemisinin-based therapeutic combinations in the Bamako District, Mali].
    Eve S; Samba D; Benoît D; Diawara SI; Seidina D; Saibou D; Karim T; Drissa K; Seydou D; Fanta Mady TS; Mahamadou D
    Mali Med; 2010; 25(3):31-40. PubMed ID: 21441091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethiopia faces severe malaria epidemic. WHO predicts 15 million people could be infected.
    Das P
    Lancet; 2003 Dec; 362(9401):2071. PubMed ID: 14700064
    [No Abstract]   [Full Text] [Related]  

  • 57. Counterfeit artemisinin derivatives and Africa: update from authors.
    Newton PN; Green MD; Fernandez F
    PLoS Med; 2007 Mar; 4(3):e139. PubMed ID: 17388677
    [No Abstract]   [Full Text] [Related]  

  • 58. Measuring the AMFm.
    Tren R; Hess K
    Lancet; 2011 Mar; 377(9768):810; author reply 810-1. PubMed ID: 21377565
    [No Abstract]   [Full Text] [Related]  

  • 59. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis.
    Tozan Y; Klein EY; Darley S; Panicker R; Laxminarayan R; Breman JG
    Lancet; 2010 Dec; 376(9756):1910-5. PubMed ID: 21122910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Public health. Optimizing investments in malaria treatment and diagnosis.
    Cohen JM; Woolsey AM; Sabot OJ; Gething PW; Tatem AJ; Moonen B
    Science; 2012 Nov; 338(6107):612-4. PubMed ID: 23118172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.